Myrbetriq ER 50 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F4C2S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,432
Award facts
- Contract value 100% obligated
- $11,432.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count packaging) with a ceiling value of $11,432.18. This is a firm fixed-price delivery order with no set-aside designation, meaning the contract was competitively awarded. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary pharmaceutical distribution center.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The SPE2DX contract vehicle provides comprehensive global pharmaceutical support, enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare customers. This delivery order for Myrbetriq ER tablets, a urological medication used to treat overactive bladder, exemplifies the routine pharmaceutical procurement occurring under this substantial prime contract vehicle. The award has an ultimate completion date of November 25, 2025.
Quick answers
Who was awarded contract SPE2DR26F4C2S?
SPE2DR26F4C2S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F4C2S worth?
The government has obligated $11,432 on SPE2DR26F4C2S.
Is contract SPE2DR26F4C2S an order under another contract?
Yes. SPE2DR26F4C2S is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4C2S competed?
The extent of competition for SPE2DR26F4C2S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award